Short general description of Daklinza (daclatasvir) Daklinza (daclatasvir) is an antiviral medication that is used in combination with other drugs to treat chronic hepatitis C virus (HCV) infection. It belongs to a class of medications called direct-acting antivirals (DAAs), which work by stopping the virus from multiplying and spreading in the body. How Daklinza works Daklinza targets a protein in the HCV called NS5A, which is essential for viral replication. By inhibiting the NS5A protein, Daklinza prevents the virus from reproducing and helps to slow down or stop the progression of the infection. Usage and dosage of Daklinza Daklinza is …
Tag: Daklinza, Daclatasvir
Overview of Daklinza (Daklatasvir) Daklinza, also known by its generic name Daklatasvir, is a prescription medication used in the treatment of chronic hepatitis C. It is typically administered in combination with other antiviral medications to increase its effectiveness. Developed by Bristol Myers Squibb, Daklinza has been approved by the U.S. Food and Drug Administration (FDA) since 2015. Mechanism of Action Daklinza works by inhibiting the HCV protein NS5A, which is essential for the replication of the hepatitis C virus. By blocking this protein, the medication prevents the virus from multiplying and spreading throughout the body. This helps to reduce liver …